Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Unknown × fludarabine × Clear all

Phase

Phase 1 27 Phase 2 21 Phase 1/2 19 Phase EARLY_PHASE1 15 Phase 3 5 Phase NA 4 Phase 4 3 Phase 2/3 1

Status

Recruiting 3 Terminated 2 Completed 2 Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

Docetaxel 16 Cisplatin 16 Capecitabine 15 Drug Therapy 14 Cyclophosphamide 13 Oxaliplatin 12 Fluorouracil 12 Radiotherapy 11 Paclitaxel 9 apatinib 8 Epirubicin 7 Doxorubicin 7 Decitabine 7 sintilimab 6 Methotrexate 6 Gemcitabine 6 Carboplatin 6 Busulfan 6 anlotinib 5 XELOX 5 Pemetrexed 5 Leucovorin 5 Etoposide 5 Dexamethasone 5 lenvatinib 4 camrelizumab 4 Surgical Procedures, Operative 4 Radiosurgery 4 Neoadjuvant Therapy 4 Cytarabine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04217278 2023-05-10

COSI

University of Birmingham

Phase 2/3 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡